Impact of ureteroscopy on nephroureterectomy and standards of care compliance in upper tract urothelial carcinoma: the BAUS UK I‐DUNC audit
BJU International · 2026
DOI: 10.1111/bju.70013 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift BJU International, 2026. Verfasst von Bhavan Prasad Rai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Carcinoma, Transitional Cell, Guideline Adherence, Kidney Neoplasms, Nephroureterectomy. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Objectives
To evaluate diagnostic practices in the United Kingdom (UK) prior to radical nephroureterectomy (RNU) for suspected upper tract urothelial carcinoma (UTUC) and assess their impact on early oncological outcomes. The audit examined compliance post‐operative intravesical Mitomycin C (MMC) instillation and adjuvant chemotherapy for ≥pT2 disease. Materials and Methods This national audit, by the British Association of Urological Surgeons (BAUS), invited all NHS hospitals performing RNU for non‐metastatic UTUC. Retrospective anonymised data were collected. Outcomes included time from imaging to RNU, use of MMC, adjuvant chemotherapy, bladder recurrence, surgical margins, extravesical metastasis, and final histology. Statistical analysis used Mann‐Whitney U, Chi‐square/Fisher's exact test, and multivariate logistic regression.
Results
A total of 877 patients who underwent RNU across 70 hospitals were analysed (median 10 cases per hospital). Diagnostic ureteroscopy (d‐URS) was performed in 61.3% of cases, delaying RNU by a median of 53 days (130 vs 77 days; P < 0.01). Voided urine cytology was recorded in 34.3%. Among patients with high‐grade and/or ≥ pT1 disease, 89% had positive cytology. MMC was administered in 45.1% of ≥pT2 cases and adjuvant chemotherapy in 46%. Bladder recurrence was significantly higher in patients undergoing d‐URS (26.6% vs 12.3%; P < 0.01), as were positive margins in ≥pT2 tumours (24% vs 14%; P = 0.03). Although not statistically significant, d‐URS was associated with more metastases (27.2% vs 19.2%) and fewer non‐UTUC diagnoses (5.5% vs 8.6%). Multivariate analysis showed that d‐URS independently predicted bladder recurrence and margin positivity in ≥pT2 disease.
Conclusions
Our audit showed that d‐URS is associated with significant treatment delays, increased rates of metachronous bladder cancer recurrence, and higher surgical positive margin rates in patients with ≥pT2 disease. Compliance with MMC therapy and adjuvant chemotherapy was low. This national audit highlights the need for risk‐stratified diagnostic pathways, multidisciplinary expertise, and establishment of quality performance indicators to improve care and outcomes in UTUC management in the UK.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
- Department of Urology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
- Department of Urology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
- Department of Urology, Bristol Urology Institute, Southmead Hospital, Bristol, UK.
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
- Western General Hospital, Edinburgh, UK.
ORCID-Profile: Bhavan Prasad Rai, Robert Geraghty, Joe Philip, Jonathan Aning, Alexander Laird, James Armitage
Zitieren
APA
Rai, B. P., Geraghty, R., Walton, T., Calvert, R., Philip, J., Aning, J., Hanchanale, V., Laird, A., & Armitage, J. (2026). Impact of ureteroscopy on nephroureterectomy and standards of care compliance in upper tract urothelial carcinoma: the BAUS UK I‐DUNC audit. BJU International. https://doi.org/10.1111/bju.70013
Vancouver
Rai BP, Geraghty R, Walton T, Calvert R, Philip J, Aning J, et al. Impact of ureteroscopy on nephroureterectomy and standards of care compliance in upper tract urothelial carcinoma: the BAUS UK I‐DUNC audit. BJU International. 2026. doi:10.1111/bju.70013
BibTeX
@article{Rai2026,
author = {Rai, Bhavan Prasad and Geraghty, Robert and Walton, Thomas and Calvert, Robert and Philip, Joe and Aning, Jonathan and Hanchanale, Vishwanath and Laird, Alexander and Armitage, James},
title = {Impact of ureteroscopy on nephroureterectomy and standards of care compliance in upper tract urothelial carcinoma: the BAUS UK I‐DUNC audit},
journal = {BJU International},
year = {2026},
doi = {10.1111/bju.70013}
}
EUVIMED